Search Results - "Huang, Yunyuan"

Refine Results
  1. 1

    N‑Acylamino Saccharin as an Emerging Cysteine-Directed Covalent Warhead and Its Application in the Identification of Novel FBPase Inhibitors toward Glucose Reduction by Wen, Wuqiang, Cao, Hongxuan, Xu, Yixiang, Ren, Yanliang, Rao, Li, Shao, Xubo, Chen, Han, Wu, Lixia, Liu, Jiaqi, Su, Chen, Peng, Chao, Huang, Yunyuan, Wan, Jian

    Published in Journal of medicinal chemistry (14-07-2022)
    “…With a resurgence of covalent drugs, there is an urgent need for the identification of new moieties capable of cysteine bond formation. Herein, we report on…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Specific tracking of monoamine oxidase A in heart failure models by a far-red fluorescent probe with an ultra large Stokes shift by Li, Xinming, Shi, Donglei, Song, Yihe, Xu, Yixiang, Gao, Ying, Qiu, Wenjing, Chen, Xin, Li, Xiaokang, Huang, Yunyuan, Feng, Yanjun, Li, Baoli, Guo, Yuan, Li, Jian

    Published in Chinese chemical letters (01-03-2022)
    “…Monoamine oxidase A (MAO-A) is a prominent myocardial source of reactive oxygen species (ROS), and its expression and activity are strongly increased in…”
    Get full text
    Journal Article
  4. 4

    Anti-aging effects of chlorpropamide depend on mitochondrial complex-II and the production of mitochondrial reactive oxygen species by Mao, Zhifan, Liu, Wenwen, Huang, Yunyuan, Sun, Tianyue, Bao, Keting, Feng, Jiali, Moskalev, Alexey, Hu, Zelan, Li, Jian

    Published in Acta pharmaceutica Sinica. B (01-02-2022)
    “…Sulfonylureas are widely used oral anti-diabetic drugs. However, its long-term usage effects on patients’ lifespan remain controversial, with no reports of…”
    Get full text
    Journal Article
  5. 5

    A Senomorphlytic Three-Drug Combination Discovered in Salsola collina for Delaying Aging Phenotypes and Extending Healthspan by Wang, Jiqun, Liu, Wenwen, Huang, Yunyuan, Wang, Guangwei, Guo, Xiaobo, Shi, Donglei, Sun, Tianyue, Xiao, Chaojiang, Zhang, Chao, Jiang, Bei, Guo, Yuan, Li, Jian

    Published in Advanced science (01-09-2024)
    “…The pursuit of pharmacological interventions in aging aims focuses on maximizing safety and efficacy, prompting an exploration of natural products endowed with…”
    Get full text
    Journal Article
  6. 6

    Structural repurposing of SGLT2 inhibitor empagliflozin for strengthening anti-heart failure activity with lower glycosuria by Xu, Yixiang, Zhang, Chao, Jiang, Kai, Yang, Xinchun, Chen, Feng, Cheng, Zhiyang, Zhao, Jinlong, Cheng, Jiaxing, Li, Xiaokang, Chen, Xin, Zhou, Luoyifan, Duan, Hao, Huang, Yunyuan, Xiang, Yaozu, Li, Jian

    Published in Acta pharmaceutica Sinica. B (01-04-2023)
    “…Sodium-glucose cotransporter 2 (SGLT2) inhibitors have been reapproved for heart failure (HF) therapy in patients with and without diabetes. However, the…”
    Get full text
    Journal Article
  7. 7

    Advances in inhibitor development targeting the PWWP domain by Huang, Yunyuan, Li, Yanxi, Min, Jinrong

    “…The PWWP domain binds to both histone and DNA of a nucleosome in a bivalent way. PWWP domain-containing proteins are involved in different biological…”
    Get full text
    Journal Article
  8. 8

    Inhibitors targeting the PWWP domain-containing proteins by Huang, Yunyuan, Li, Boyi, Wu, Zhibin, Liu, Ke, Min, Jinrong

    Published in European journal of medicinal chemistry (15-12-2024)
    “…PWWP domain-containing proteins play a pivotal role in chromatin-mediated biological processes, and their aberrant regulation is linked to various human…”
    Get full text
    Journal Article
  9. 9

    N/C-degron pathways and inhibitor development for PROTAC applications by Wu, Zhibin, Huang, Yunyuan, Liu, Ke, Min, Jinrong

    “…Ubiquitination is a fascinating post-translational modification that has received continuous attention since its discovery. In this review, we first provide a…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Cov_FB3D: A De Novo Covalent Drug Design Protocol Integrating the BA-SAMP Strategy and Machine-Learning-Based Synthetic Tractability Evaluation by Wei, Lin, Wen, Wuqiang, Rao, Li, Huang, Yunyuan, Lei, Mengting, Liu, Kai, Hu, Saiya, Song, Rongrong, Ren, Yanliang, Wan, Jian

    “…De novo drug design actively seeks to use sets of chemical rules for the fast and efficient identification of structurally new chemotypes with the desired set…”
    Get full text
    Journal Article
  12. 12

    Discovery of novel dual RAGE/SERT inhibitors for the potential treatment of the comorbidity of Alzheimer's disease and depression by Zhang, Chao, Wang, Lan, Xu, Yixiang, Huang, Yunyuan, Huang, Junyang, Zhu, Jin, Wang, Wei, Li, Wangsheng, Sun, Annan, Li, Xiaokang, Zhang, Haiyan, Li, Jian

    Published in European journal of medicinal chemistry (05-06-2022)
    “…Depression is identified as one of the most common psychiatric symptoms in Alzheimer's disease (AD). The comorbidity of AD and depression increases the burden…”
    Get full text
    Journal Article
  13. 13

    Rapid Repurposing of Novel Combination Drugs for the Treatment of Heart Failure via a Computationally Guided Network Screening Approach by Huang, Yunyuan, Wang, Jiqun, Liu, Jiaqi, Shi, Donglei, Li, Xiaokang, Wang, Manjiong, Lu, Taotao, Jiang, Bei, Xia, Conglong, Lin, Houwen, Xu, Yixiang, Li, Jian

    “…Combination drugs, characterized by high efficacy and few side effects, have received extensive attention from pharmaceutical companies and researchers for the…”
    Get full text
    Journal Article
  14. 14

    Discovery of novel allosteric site and covalent inhibitors of FBPase with potent hypoglycemic effects by Huang, Yunyuan, Wei, Lin, Han, Xinya, Chen, Haifeng, Ren, Yanliang, Xu, Yanhong, Song, Rongrong, Rao, Li, Su, Chen, Peng, Chao, Feng, Lingling, Wan, Jian

    Published in European journal of medicinal chemistry (15-12-2019)
    “…Fructose-1,6-bisphosphatase (FBPase) is an essential enzyme of GNG pathway. Significant advances demonstrate the FBPase plays a critical role in treatment of…”
    Get full text
    Journal Article
  15. 15

    Identification of the New Covalent Allosteric Binding Site of Fructose-1,6-bisphosphatase with Disulfiram Derivatives toward Glucose Reduction by Huang, Yunyuan, Xu, Yixiang, Song, Rongrong, Ni, Shuaishuai, Liu, Jiaqi, Xu, Yanhong, Ren, Yanliang, Rao, Li, Wang, Yingjie, Wei, Lin, Feng, Lingling, Su, Chen, Peng, Chao, Li, Jian, Wan, Jian

    Published in Journal of medicinal chemistry (11-06-2020)
    “…Fructose 1,6-bisphosphatase (FBPase) has attracted substantial interest as a target associated with cancer and type 2 diabetes. Herein, we found that…”
    Get full text
    Journal Article
  16. 16

    Photoactivatable senolysis with single-cell resolution delays aging by Shi, Donglei, Liu, Wenwen, Gao, Ying, Li, Xinming, Huang, Yunyuan, Li, Xiaokang, James, Tony D, Guo, Yuan, Li, Jian

    Published in Nature aging (01-03-2023)
    “…Strategies that can selectively eliminate senescent cells (SnCs), namely senolytics, have been shown to promote healthy lifespan. However, it is challenging to…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Biological evaluation and SAR analysis of novel covalent inhibitors against fructose-1,6-bisphosphatase by Han, Xinya, Huang, Yunyuan, Wei, Lin, Chen, Haifeng, Guo, Yanrong, Tang, Zilong, Hu, Wei, Xia, Qinfei, Wang, Qi, Yan, Jufen, Ren, Yanliang

    Published in Bioorganic & medicinal chemistry (15-09-2020)
    “…[Display omitted] Fructose-1,6-bisphosphatase (FBPase) is an attractive target for affecting the GNG pathway. In our previous study, the C128 site of FBPase…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Identification of Guaifenesin–Andrographolide as a Novel Combinatorial Drug Therapy for Epilepsy Using Network Virtual Screening and Experimental Validation by Huang, Yunyuan, Xu, Haiyan, Wang, Pei, Gu, Rurong, Li, Xiaokang, Xu, Yixiang, Wang, Jiqun, Qiao, Sicong, Shi, Donglei, Gao, Zhaobing, Li, Jian

    Published in ACS chemical neuroscience (06-04-2022)
    “…Combinatorial drug therapy has attracted substantial attention as an emerging strategy for the treatment of diseases with complex pathological mechanisms. We…”
    Get full text
    Journal Article